• Explore /
  • Poster
  • / Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL).

Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL).

Abstract Poster

Authors

null

Nicolas Sayegh

Huntsman Cancer Institute-University of Utah Health Care, Salt Lake City, UT

Nicolas Sayegh , Nishita Tripathi , Beverly Chigarira , Yeonjung Jo , Taylor Ryan McFarland , Adam Kessel , Roberto Nussenzveig , Haoran Li , Clara Tandar , Divyam Goel , Kamal Kant Sahu , Benjamin Haaland , Benjamin L. Maughan , Umang Swami , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 123)

DOI

10.1200/JCO.2022.40.6_suppl.123

Abstract #

123

Poster Bd #

F11

Abstract Disclosures

Similar Posters

First Author: Andrew W Hahn

Poster

2024 ASCO Genitourinary Cancers Symposium

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

First Author: Benjamin L. Maughan

First Author: Mamta Parikh

First Author: Vinay Mathew Thomas